Related Experiment Video
Updated: Jun 28, 2025

Synthesis of a Borylated Ibuprofen Derivative Through Suzuki Cross-Coupling and Alkene Boracarboxylation Reactions
Published on: November 30, 2022
Single-dose ibuprofen induced Stevens-Johnson Syndrome.
Ahmed Qasim Mohammed Alhatemi1, Hashim Talib Hashim2, Muhamad Abdulrahman Shyea Al-Tarbosh1
1Department of Internal Medicine Al Nasiriyah Teaching Hospital Thi Qar Iraq.
A single dose of ibuprofen rarely caused Stevens-Johnson Syndrome (SJS), a severe skin reaction. This highlights the need for increased healthcare vigilance and public awareness for safer medication use.
Area of Science:
- Dermatology
- Pharmacology
- Clinical Medicine
Background:
- Stevens-Johnson Syndrome (SJS) is a severe mucocutaneous disorder.
- It is often triggered by medications, including nonsteroidal anti-inflammatory drugs like ibuprofen.
Observation:
- A case report details a 45-year-old woman who developed SJS after a single ibuprofen dose.
- This adverse drug reaction highlights the potential risks associated with common medications.
Findings:
- Ibuprofen, even in a single dose, can rarely induce Stevens-Johnson Syndrome.
- Prompt identification and management of SJS are critical for patient prognosis.
Implications:
- Healthcare providers must maintain vigilance for SJS when prescribing ibuprofen.
- Public awareness and patient education are essential for recognizing SJS symptoms and ensuring medication safety.
More Related Videos
10:10Transport Properties of Ibuprofen Encapsulated in Cyclodextrin Nanosponge Hydrogels: A Proton HR-MAS NMR Spectroscopy Study
Published on: August 15, 2016
06:31Precision Implementation of Minimal Erythema Dose MED Testing to Assess Individual Variation in Human Inflammatory Response
Published on: October 3, 2019
Related Concept Videos
Drugs for Treatment of Constipation-Predominant IBS
Drugs for Treatment of Ulcerative Colitis in IBD
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Drug Metabolism: Phase I Reactions